HI Form 4: Gary Collar receives 295 restricted stock units
Rhea-AI Filing Summary
Hillenbrand director Gary L. Collar was granted a total of 295 Restricted Stock Units (RSUs) on 09/30/2025 across previously established deferred stock award schedules. Each RSU represents the contingent right to receive one share of Hillenbrand common stock and accrues dividend equivalents on record dates. Several of the RSU tranches vest immediately but delivery is restricted until a change in control, the director's death or disability, or one day after the director ceases to serve; other tranches vest on the earlier of the next annual meeting or one year from grant and are subject to the same delivery conditions. All reported RSUs are held in direct beneficial ownership form following the transactions.
Positive
- 295 RSUs granted aligns director compensation with shareholder value through equity rather than cash
- Several RSU tranches vest immediately, strengthening retention while delivery remains contingent on triggering events
- RSUs accrue dividend equivalent rights, preserving economic parity with common shareholders
Negative
- Delivery of immediately vested RSUs is restricted until change in control, death/disability, or end of directorship, delaying share issuance
- Form discloses multiple legacy award schedules which may increase future dilution if shares are ultimately delivered
Insights
Director received 295 RSUs under deferred award schedules on 09/30/2025.
The Form 4 shows non‑cash equity awards to a sitting director rather than open‑market purchases or sales. These awards align director pay with shareholder value because they convert to common shares under specific triggering events such as a change in control or termination of board service.
The immediate vesting language for some tranches combined with delayed delivery means the director gains economic rights (including dividend equivalents) now but actual share issuance is contingent on defined events, preserving retention and alignment features without increasing outstanding shares today.
The grants are routine deferred board compensation structured as RSUs with dividend equivalents.
The Form 4 lists multiple legacy deferred award schedules spanning grants from 2015 through 2025, with varying vesting provisions: some RSUs vest immediately but restrict delivery, while others vest on the earlier of the next annual meeting or one year from grant.
This structure indicates a mix of retention and routine annual board compensation; the total of 295 RSUs granted on 09/30/2025 is disclosed with $0 per‑unit exercise/price because these are restricted units, not option purchases.